Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use.

Journal of diabetes investigation - 1 Nov 2020

Hosokawa Yusei, Ogawa Wataru

Abstract excerpt

Administration of an sodium-glucose cotransporter 2 inhibitor to individuals with insulin resistance reduces the level of glucose disposal necessary to maintain glycemia as a result of the induced increase in urinary glucose excretion. The amount of insulin required for a certain level of glucose disposal, on which the evaluation of insulin resistance is usually based, might thus decrease even without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Genetic Predisposition to Disease
Share to Insulin Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 32469141
DOI: 10.1111/jdi.13309
PMCID: PMC7610101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use.PMID 32469141Read ↗

Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintySemantic proximity Read ↗

Development of SGLT1 and SGLT2 inhibitors.Semantic proximity Read ↗

SGLT2 Inhibitors and Potential Applications in Treating Metabolic SyndromeSemantic proximity Read ↗

The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin SensitivitySemantic proximity Read ↗

How to measure insulin sensitivity.Semantic proximity Read ↗

Luminal Inhibition of α-Glucosidase Activity Improves Insulinogenic Actions on Glycemic and Lipid Parameters in Obese T2DM RatsSemantic proximity Read ↗

SGLT2 inhibitor-induced euglycaemic diabetic ketoacidosis may be due to abrupt, severe and transient impaired glucose sensing in susceptible individuals with a hitherto unrecognised beta cell SGLT variant.Semantic proximity Read ↗

Inhibiting renal sodium-glucose transport in diabetes: pass the salt.Semantic proximity Read ↗

Measurement of insulin resistance in vivo.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.